Vyant Bio, Inc.
VYNTDelisted May 4, 2023- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001349929
Vyant Bio, Inc. was delisted on May 4, 2023; its insiders filed their last Form 4 on Feb 27, 2023; 17 institutions reported holding it in 13F filings for Q1 2023, worth $136.8K in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Vyant Bio, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 29 | 23 | −6 |
| Shares | 2.25M | 2.26M | +10.9K (+0.5%) |
| Value | $8.41M | $5.27M | −$3.15M (−37.4%) |
New holders (1)
Institutions that held Vyant Bio, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 109,200 | $254.0K | 0.00% |
Sold out (7)
Institutions that held Vyant Bio, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| GWM Advisors LLC | 56,017 | $210.0K |
| Citadel Advisors LLC | 26,035 | $97.0K |
| Virtu Financial LLC | 20,504 | $77.0K |
| Charles Schwab Investment Management Inc | 13,043 | $49.0K |
| Bank of Montreal | 10,000 | $37.0K |
| UBS Group AG | 1,299 | $5.00K |
| Bank of America Corp | 10 | $0 |